The European Medicines Agency (EMA) has adopted a new policy which will, it says, provide the public with wider access than ever before to documents in its possession related to medicines for human and veterinary use.
It will, however, ensure that personal data and commercial confidential information remain adequately protected, the Agency adds.
“Openness and transparency are enshrined as fundamental values in the Agency’s regulatory framework,” said Noël Wathion, the EMA’s head of patient health protection. “They allow our stakeholders to understand the basis for the Agency’s scientific decision-making and provide for the basis on which patients and healthcare professionals can have confidence in our opinions and information relating to medicines.”
Looking beyond the spin of Big Pharma PR. But encouraging gossip. Come in and confide, you know you want to! “I’ll publish right or wrong. Fools are my theme, let satire be my song.” Email: jackfriday2011(at)hotmail.co.uk
Wednesday, December 01, 2010
Let the sun shine in! - EMA widens public access to documents
via pharmatimes.com
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment